Classification of central nervous system agents by least squares support vector machine based on their structural descriptors: A comparative study

Chemometrics and Intelligent Laboratory Systems

Volumn 110, Issue 1, 2012, Pages 102-107

  Ghorbanzad'e, Mehdi ^a   Fatemi, Mohammad Hossein ^a  

^a UNIVERSITY OF MAZANDARAN   (Iran)

Author keywords

Blood brain barrier; Central nervous system; Classification; Discriminant analysis; Least squares support vector machine

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS;

ACCURACY; ARTICLE; BLOOD BRAIN BARRIER; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISCRIMINANT ANALYSIS; DRUG CLASSIFICATION; DRUG PENETRATION; DRUG STRUCTURE; LEAST SQUARES SUPPORT VECTOR MACHINE; LINEAR DISCRIMINANT ANALYSIS; PRIORITY JOURNAL; QUADRATIC DISCRIMINANT ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE;

EID: 83655184755     PISSN: 01697439     EISSN: 18733239     Source Type: Journal    
DOI: 10.1016/j.chemolab.2011.10.003     Document Type: Article

References (62)

1. Liu X., Tu M., Kelly R.S., Chen C., Smith B.J. Development of a computational approach to predict blood-brain barrier permeability. Drug Metabolism and Disposition 2004, 32:132-139.
2. Begley D.J. Understanding and circumventing the blood-brain barrier. Acta Paediatrica 2003, 92:83-91.
3. Banks W.A. Characteristics of compounds that cross the blood-brain barrier. BMC Neurology 2009, 9. 10.1186/1471-2377-9-S1-S3.
4. Smith Q.R. A review of blood-brain barrier transport techniques. Methods in Molecular Medicine 2003, 89:193-208.
5. Gumbleton M., Audus K.L. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. Journal of Pharmaceutical Sciences 2001, 90:1681-1698.
6. Reichel A., Begley D.J., Abbott N.J. An overview of in vitro techniques for blood-brain barrier studies. Methods in Molecular Medicine 2003, 89:307-324.
7. Eddy E.P., Maleef B.E., Hart T.K., Smith P.L. In vitro models to predict blood-brain barrier permeability. Advanced Drug Delivery Reviews 1997, 23:185-198.
8. Reichel A., Begley D.J. Potential of immobolized artificial membranes for predicting drug penetration across the blood brain barrier. Pharmaceutical Research 1998, 15:1270-1274.
9. Katritzky A.R., Kuanar M., Slavov S., Dobchev D.A., Fara D.C., Karelson M., Acree W.E., Solov'eve V.P., Varnek A. Correlation of blood-brain penetration using structural descriptors. Bioorganic & Medicinal Chemistry 2006, 14:4888-4917.
10. Van der Waterbeemd H., Gifford E. ADMET in silico modelling: towards prediction paradise?. Nature Reviews Drug Discovery 2003, 2:192-204.
11. Norinder U., Haeberlain M. Computational approaches to the prediction of the blood-brain Distribution. Advanced Drug Delivery Reviews 2002, 54:291-313.
12. Lobell M., Molnar L., Keseru M. Recent advances in the prediction of blood-brain partitioning from molecular structure. Journal of Pharmaceutical Sciences 2003, 92:360-370.
13. Goodwin J.T., Clark D.E. In silico predictions of blood-brain barrier penetration: considerations to "keep in mind". Journal of Pharmacology and Experimental Therapeutics 2005, 315:477-483.
14. Abraham M.H., Ibrahim A., Zhao Y.H., Acree W.E. A data base for partition of volatile organic compounds and drugs from blood/plasma/serum to brain, and an LFER analysis of the data. Journal of Pharmaceutical Sciences 2006, 95:2091-2100.
15. Clark D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. Journal of Pharmaceutical Sciences 1999, 88:815-821.
16. Clark D.E. Prediction of intestinal absorption and blood-brain barrier penetration by computational methods. Combinatorial Chemistry & High Throughput Screening 2001, 4:477-496.
17. Engkvist O., Drede P., Rester U.J. Prediction of CNS activity of compound libraries using substructure analysis. Journal of Chemical Information and Computer Sciences 2003, 43:155-160.
18. Ajay, Bemis G.W., Murcko M.A. Designing libraries with CNS activity. Journal of Medicinal Chemistry 1999, 42:4942-4951.
19. Adenot M., Lahana R.J.J. Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates. Journal of Chemical Information and Computer Sciences 2004, 44:239-248.
20. Zhao Y.H., Abraham M.H., Ibrahim A., Fish P.V., Cole S., Lewis M.L., de Groot M.J., Reynolds D.P. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes. Journal of Chemical Information and Modeling 2007, 47:170-175.
21. Doniger S., Hofmann T., Yeh J.J. Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms. Journal of Computational Biology 2002, 9:849-864.
22. Li H., Yap C.W., Ung C.Y., Xue Y., Cao Z.W., Chen Y.Z. Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods. Journal of Chemical Information and Modeling 2005, 45:1376-1384.
23. Zupan J., Novic M., Gasteiger J. Neural networks with counter-propagation learning strategy used for modeling. Chemometrics and Intelligent Laborary Systems 1995, 27:175-187.
24. Zupan J., Novic M., Ruisánchez I. Kohonen and counterpropagation artificial neural networks in analytical chemistry. Chemometrics and Intelligent Laborary Systems 1997, 38:1-23.
25. Ballabio D., Kokkinofta R., Todeschini R., Theocharis C.R. Characterization of the traditional Cypriot spirit Zivania by means of counterpropagation artificial neural networks. Chemometrics and Intelligent Laborary Systems 2007, 87:52-58.
26. Cristianini N., Shawe-Taylor J. Support VectorMachines and Other Kernel-based Learning Methods 2000, Cambridge University Press, Cambridge, U.K.
27. Luan F., Zhang R., Zhao C., Yao X., Liu M., Hu Z., Fan B. Classification of the carcinogenicity of N-Nitroso compounds based on support vector machines and linear discriminant analysis. Chemical Research in Toxicology 2005, 18:198-203.
28. Suykens J.A.K., van Gestel T., de Brabanter J., de Moor B., Vandewalle J. Least-Squares Support Vector Machines 2002, World Scientific, Singapore.
29. van de Waterbeemd H., Camenish G., Folkers G., Chretien J.R., Raevsky O.A.J. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. Journal Drug Targeting 1998, 6:151-165.
30. Negwer M. Organic-Chemical Drugs and their Synonyms 1987, Akademie, Berlin.
31. Galvão R.K.H., Araujo M.C.U., José G.E., Pontes M.J.C., Silva E.C., Saldanha T.C.B. A method for calibration and validation subset partitioning. Talanta 2005, 67:736-740.
32. HyperChem Release 7.0 for windows 2002, Hypercube, Inc.
33. http://www.disat.unimib.it/chm/Dragon.html.
34. Cabrera Pérez M.A., Sanz M.B. In silico prediction of central nervous system activity of compounds. Identification of potential pharmacophores by the TOPS-MODE approach. Bioorganic & Medicinal Chemistry 2004, 12:5833-5843.
35. Lombardo F., Blake J.F., Curatolo W.J. Computation of brain-blood partitioning of organic solutes via free energy calculations. Journal of Medicinal Chemistry 1996, 39:4750-4755.
36. Abraham M.H., Chada S., Mitchell R. Hydrogen bonding. 33 factors that influence the distribution of solutes between blood and brain. Journal of Pharmaceutical Sciences 1994, 83:1257-1268.
37. Rezzi S., Axelson D.E., Héberger K., Reniero F., Mariani C., Guillou C. Classification of olive oils using high throughput flow 1H NMR fingerprinting with principal component analysis, linear discriminant analysis and probabilistic neural networks. Analytica Chimica Acta 2005, 552:13-24.
38. Fisher R.A. The use of multiple measurements in taxonomic problems. Annals of Eugenics 1936, 7:179-188.
39. Vaid T.P., Burl M.C., Lewis N.S. Comparison of the performance of different discriminant algorithms in analyte discrimination tasks using an array of carbon black-polymer composite vapor detectors. Analytical Chemistry 2001, 73:321-331.
40. Duda R.O., Hart P.E. Pattern classification and scene analysis 1973, John Wiley & Sons, New York.
41. Hernández-Caraballo E.A., Avila-Gómez R.M., Capote T., Rivas F., Pérez A.G. Classification of venezuelan spirituous beverages by means of discriminant analysis and artificial neural networks based on their Zn, Cu and Fe concentrations. Talanta 2003, 60:1259-1267.
42. Vapnik V.N. The Nature of Statistical Learning Theory 1995, Springer.
43. Xie L., Ying Y., Ying T. Classification of tomatoes with different genotypes by visible and short-wave near-infrared spectroscopy with least-squares support vector machines and other chemometrics. Journal of Food Engineering 2009, 94:34-39.
44. Devos A., Lukasa L., Suykensa J.A.K., Vanhammea L., Tateb A.R., Howec F.A., Majósd C., Moreno-Torrese A., van der Graaff M., Arúsg C., Van Huffela S. Classification of brain tumours using short echo time 1H MR spectra. Journal of Magnetic Resonance 2004, 170:164-175.
45. Fatemi M.H., Ghorbanzad'e M. Classification of drugs according to their milk / plasma concentration ratio. European Journal of Medicinal Chemistry 2010, 45:5051-5055.
46. Matthews B.W. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochimica et Biophysica Acta 1975, 405:442-451.
47. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960, 20:37-46.
48. Fielding A.H., Bell J.F. A review of methods for the measurement of prediction errors in conservation presence/absence models. Environmental Conservation 1997, 24:38-49.
49. Forbes A.D. Classification-algorithm evaluation-5 performance-measures based on confusion matrices. Journal of Clinical Monitoring 1995, 11:189-206.
50. Manel S., Williams H.C., Ormerod S.J. Evaluating presence-absence models in ecology: the need to account for prevalence. Journal of Applied Ecology 2001, 38:921-931.
51. Spychera S., Nendzab M., Gasteigera J. Comparison of different classification methods applied to a mode of toxic action data set. QSAR and Combinatorial Science 2004, 23:779-791.
52. Bishop C. Neural networks for pattern recognition 1997, Clarendon Press, Oxford.
53. Yuan Y., Zhang R., Luo L. Classification study of novel piperazines as antagonists for the melanocortin-4 receptor based on least-squares support vector machines. Chemometrics and Intelligent Laborary Systems 2009, 96:144-148.
54. Fatemi M.H., Baher E., Ghorbanzad'e M. Predictions of chromatographic retention indices of alkylphenols with support vector machines and multiple linear regression. Journal of Separation Science 2009, 32:4133-4142.
55. Brown C.D., Davis H.T. Receiver operating characteristics curves and related decision measures: a tutorial. Chemometrics and Intelligent Laborary Systems 2006, 80:24-38.
56. Randic M. Molecular shape profiles. Journal of Chemical Information and Computer Sciences 1995, 35:373-382.
57. Rose K., Hall L.H., Kier L.B. Modeling blood-brain barrier partitioning using the electrotopological state. Journal of Chemical Information and Computer Sciences 2002, 42:651-666.
58. Balaban A.T., Ciubotariu D., Medeleanu M. Topological indices and real number vertex invariants based on graph eigenvalues or eigenvectors. Journal of Chemical Information and Computer Sciences 1991, 31:517-523.
59. Needbam D.E., Wei I., Seybold P.G. Molecular modeling of the physical properties of the alkanes. Journal of the American Chemical Society 1988, 110:4186-4194.
60. Lapinsh M., Prusis P., Mutule I., Mutulis F., Wikberg J. QSAR and proteo-chemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes. Journal of Medicinal Chemistry 2003, 46:2572-2579.
61. Saquib M., Gupta M.K., Sagar R., Prabhakar Y.S., Shaw A.K., Kumar R., Maulik P.R., Gaikwad A.N., Sinha S., Srivastava A.K., Chaturvedi V., Srivastava R., Srivastava B.S. C-3 Alkyl/arylalkyl-2,3-dideoxy Hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study. Journal of Medicinal Chemistry 2007, 50:2942-2950.
62. Vicente E., Duchowicz P.R., Castro E.A., Monge A. QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents. Journal of Molecular Graphics and Modelling 2009, 28:28-36.